Home
This site is intended for healthcare professionals

Latest Advances in Thrombosis Prevention & Management for 2025

20th Nov 2025
2:00 - 2:45pm (GMT)
20th Nov 2025
2:00 - 2:45pm (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
Online

Description

This program is supported through an independent educational grant from Johnson & Johnson and Bristol Myers Squibb. It is intended exclusively for healthcare professionals globally.

In this 45-minute live webinar, national cardiovascular experts Jennifer Rymer, MD and Siddharth M. Patel, MD provide practical, case-based insights on optimizing thrombosis management in acute coronary syndrome (ACS), atrial fibrillation (AF), and secondary stroke prevention (SSP). Drawing on the latest guidelines and clinical trial evidence, webinar demonstrates how to apply validated risk assessment tools and tailor antithrombotic therapy to balance thrombotic and bleeding risk in high-risk patients.

Accreditation: 0.75 AMA PRA Category 1 Credit™.

This interactive session features clinical polling, real-world scenarios, and expert Q&A—helping healthcare professionals sharpen their ability to identify high-risk patients and select the right anticoagulation strategies across diverse cardiovascular settings.

Session Highlights

  • Risk tools in action: Use CHA₂DS₂-VASc, HAS-BLED, and GRACE scoring systems to stratify risk in AF, ACS, and SSP.
  • Tailored treatment plans: Optimize DOAC selection and dosing based on patient-specific thrombotic and bleeding risks.
  • Avoid the risk-treatment paradox: Improve adherence to evidence-based strategies while addressing bleeding concerns.
  • Real-time learning: Participate in live polling and expert-led Q&A to address everyday clinical decision-making challenges.

Who Should Watch

  • Cardiologists
  • Electrophysiologists
  • Interventional Cardiologists
  • Cardiac Surgeons
  • Primary Care Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Other U.S.-based HCPs managing thrombosis in AF, ACS, or stroke

Presented by

Jennifer A. Rymer, MD, MBA, MHS – is the John Bush Simpson Assistant Professor of Medicine at Duke University School of Medicine and a faculty member at the Duke Clinical Research Institute. She is an interventional cardiologist specializing in coronary and peripheral vascular interventions. Dr. Rymer’s research focuses on clinical trials and implementation science in acute myocardial infarction and peripheral artery disease, with grant funding from the NIH, American Heart Association, and industry partners.

Siddharth M. Patel, MD, MPH – is an Associate Physician in the Cardiovascular Division at Brigham and Women’s Hospital, an Instructor of Medicine at Harvard Medical School, and an Investigator in the TIMI Study Group. He earned his medical degree from UT Southwestern Medical School and an MPH from the Harvard T.H. Chan School of Public Health. His research focuses on antithrombotic therapies in atrial fibrillation, acute and chronic heart failure, and critical care cardiology.

Continuing Education Information

This continuing education activity will be provided by Current Concepts Institute (CCI) and MedAll. Physicians, Nurse Practitioners, and Physician Assistants will be eligible for AMA PRA Category 1 Credit™; Nurses for ANCC Contact Hours. A statement of participation is available for other healthcare professionals.

Unapproved and/or off-label use disclosure

Current Concepts Institute/MedAll requires CE faculty to disclose to the participants:

1. When products or procedures being discussed are off-label, unlabelled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and

2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Disclosures

Below is a listing of all individuals who are involved in the planning and implementation of this accredited continuing education activity. All relevant financial relationships listed for these individuals have been mitigated.

Dr Jennifer Rymer has disclosed financial relationships within the past 24 months with the following ineligible companies: Chiesi, Idorsia Pharmaceuticals, Abbott, serving in advisory or investigator roles. These disclosures are made in accordance with ACCME standards to ensure transparency and objectivity in continuing education. Dr. Jennifer Rymer does not intend to reference any unlabeled or unapproved uses of products during the presentation.

Dr. Siddharth M. Patel has disclosed financial relationships within the past 24 months with the following ineligible companies. He has received consulting fees from Janssen. Through his institution, he has also received research grants from Abbott, Abiomed, Amgen, Anthos Therapeutics, ARCA Biopharma, and AstraZeneca to the TIMI Study Group. These disclosures are made in accordance with ACCME standards to ensure transparency and objectivity in continuing education.

CCI staff, MedAll staff, and all planners and reviewers have no relevant financial relationships with ineligible companies to disclose.

Activity Accreditation for Health Professions

Physicians

AMA PRA Category 1 Credits™ are available for this activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Current Concepts Institute and MedAll Education. Current Concepts Institute is accredited by the ACCME to provide continuing medical education for physicians.

Current Concepts Institute designates this online activity a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This continuing education activity is active starting 20th November 2025 and will expire on 20th November 2025. Estimated time to complete this activity: 45 minutes.

Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

How to Earn Your CME Credit:

To earn your certificate, attend the full webinar and complete the post-session assessment. A link to your certificate will be provided upon completion.

Participation Costs

There is no cost to participate in this program.

Learning objectives

Implement evidence-based risk stratification strategies to optimize thrombosis prevention and management in ACS, AF, and SSP:

  • Apply CHA₂DS₂-VASc and HAS-BLED scoring to accurately identify AF patients at high risk of stroke and determine appropriate anticoagulation therapy​.
  • Utilize validated risk assessment tools, such as GRACE and TIMI scores, to guide individualized antithrombotic treatment decisions in ACS and SSP​.
  • Improve detection and management of asymptomatic AF (AAF) and undiagnosed stroke-risk patients, ensuring timely initiation of anticoagulation​.

Individualize antithrombotic therapy selection and dosing to maximize efficacy while mitigating bleeding risks in ACS, AF, and SSP:

  • Optimize DOAC dosing and selection to ensure stroke prevention without increasing bleeding risk, reducing underuse and inappropriate substitution with antiplatelets​.
  • Address barriers to adherence and improve patient engagement in shared decision-making, ensuring informed choices about anticoagulation​.
  • Reduce inappropriate modifications of anticoagulant therapy due to bleeding concerns, ensuring alignment with clinical guidelines and real-world outcomes​.
View all

Similar events and on demand videos

 
20th Nov 2025
2:00 - 2:45pm (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
Online